← All indications
Eye Infections
Infection, moderate to severe, caused by bacteria, fungi, or viruses, which occurs either on the external surface of the eye or intraocularly with probable inflammation, visual impairment, or blindness.
Subtype terms (6)
More specific conditions that are subtypes of Eye Infections in the MeSH hierarchy.
- Corneal Ulcer
22 drugs (16 approved, 6 experimental)
- Endophthalmitis
15 drugs (14 approved, 1 experimental)
- Eye Infections, Bacterial
9 drugs (8 approved, 1 experimental)
- Eye Infections, Fungal
3 drugs (2 approved, 1 experimental)
- Eye Infections, Parasitic
1 drug approved
- Eye Infections, Viral
Drugs by status
Approved for this indication (2)
Phase 4 trials (5)
Phase 3 trials (3)
Phase 2 trials (2)
Organizations
Organization Involved with Phase 4 Indications (20)
- Merck
- University of Roma La Sapienza
- Clinica Mediterranea
- Dartmouth University
- D'Annunzio University of Chieti–Pescara
- Ophthalmic Consultants of Boston
- S.Eugenio Hospital
- Tufts University
- University of Florence
- University of Pavia
- University of Pisa
- University of Bologna
- University of California, San Francisco
- A.O. Ospedale Maggiore di Lodi
- OSPEDALE POLICLINICO G.B. ROSSI
- Aravind Eye Hospital
- University of Genoa
- Government of Italy
- University of Molise
- Ospedale Oftalmico, Torino
Organization Involved with Phase 3 Indications (29)
- Adapt Produtos Oftalmológicos Ltda.
- ISTA Pharmaceuticals
- Bausch & Lomb
- Kala Pharmaceuticals, Inc.
- Price Vision Group
- National Eye Institute (NEI)
- Duke University
- University of Rochester
- University of Cincinnati
- Virginia Eye Consultants
- Emek Medical Center
- Tauber Eye Center
- The Eye Center of Columbus
- Sall Research Medical Center
- Wolstan & Goldberg Eye Associates
- Martel Eye Medical Group
- Raymond Fong, MDPC
- Rochester Ophthalmological Group, PC
- Kozlovsky Delay & Winter Eye Consultants, LLC
- R&R Eye Research, LLC
- Tekwani Vision Center
- John-Kenyon American Eye Institute
- Westfield Nevada Eye and Ear
- Westside Research, LLC
- Technion University
- University of Sao Paulo
- Houston Eye Associates
- Lumbini Eye Institute and Hospital
- Bharatpur Eye Hospital, Nepal
Organization Involved with Phase 2 Indications (2)
Organization Involved with Phase 1 Indications (3)